A novel chimeric coronavirus spike vaccine combining SARS-CoV-2 RBD and scaffold domains from HKU-1 elicits potent neutralising antibody responses

Nicky Zoest et al

NPJ Vaccines; DOI: 10.1038/s41541-025-01323-6